Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced PRF vs PRF in Sinus Augmentation
NCT05134753Phase 3
Key facts
- Status
- Unknown
- Start
- Jan 2022
- Primary completion
- Aug 2022
- Sponsor
- Cairo University
- Modality
- Cell Therapies
- Conditions
- Maxillary atrophy
01
Overview
Phase 3, randomised trial of advanced platelet-rich fibrin in Maxillary atrophy, sponsored by Cairo University. Primary endpoint: Bone quality at 6 months. Status: unknown.
02
Design
- Study design
- Randomized
03
Who it enrols
Patients with missing posterior maxillary teeth and insufficient bone for implants, requiring sinus floor augmentation, and free from systemic or sinus diseases.
04
Endpoints
Primary
Bone quality
Secondary
Bone quantity
Beyond the preview
Go deeper on NCT05134753.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05134753.